PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : S

Records returned : 119 (on 17 May 2024 at 13:08:31).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
Sacrosidase
No Information Returned
Sacubitril/valsartan
No Information Returned
04.09.01
Safinamide
Parkinson's disease
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
03.01.01
07.01.03
Salbutamol
Delay of premature labour
Non Formulary
Formulations :
  • Infusion
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Salicylic acid
No Information Returned
Salmeterol
No Information Returned
Saquinavir mesylate
No Information Returned
10.01.03
Sarilumab
Rheumatoid arthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
Important
Severe disease only
10.01.03
Sarilumab
Any paediatric use
Red
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NHSE
Important
Specialist centres only
Saxagliptin
No Information Returned
Saxagliptin/dapagliflozin
No Information Returned
Saxagliptin/metformin
No Information Returned
Sebelipase alfa
No Information Returned
Secnidazole
No Information Returned
Secobarbital sodium
No Information Returned
10.01.03
13.05.02
13.05.03
Secukinumab
Hidradenitis suppurativa
Red
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
10.01.03
13.05.02
13.05.03
Secukinumab
Ankylosing spondylitis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NHSE
ICB
BlueTeq
10.01.03
13.05.02
13.05.03
Secukinumab
Non-radiographic axial spondyloarthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Secukinumab
Psoriatic arthritis
Red
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
BNF NICE SPC
ICB
BlueTeq
NICE
10.01.03
13.05.02
13.05.03
Secukinumab
Any paediatric use
Red
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NHSE
Important
Specialist centres only
10.01.03
13.05.02
13.05.03
Secukinumab
Psoriasis
Red
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
ICB
BlueTeq
NICE
04.09.01
Selegiline hydrochloride
Parkinson's disease
Blue
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF NICE SPC
NICE
04.09.01
Selegiline hydrochloride
Parkinson's disease (neuroprotective therapy)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Selenium
No Information Returned
Selenium sulfide
No Information Returned
06.01.02
Semaglutide
Weight management in adults
N/A
Formulations :
  • Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
01.06.02
Senna
Constipation
Green
Formulations :
  • Liquid
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
Sermorelin acetate
No Information Returned
Serrapeptase
No Information Returned
Sertindole
No Information Returned
Sertraline hydrochloride
No Information Returned
Sevelamer
No Information Returned
Sevoflurane
No Information Returned
Shingles (H/Z)
No Information Returned
Sibutramine
No Information Returned
07.04.01
Sildenafil
Benign prostatic hyperplasia
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
07.04.05
Sildenafil (Erectile Dysfunction)
Erectile dysfunction
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
1st line option
07.04.05
Sildenafil (Erectile Dysfunction)
Erectile dysfunction combination therapy
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Sildenafil (Female Sex Hormone)
No Information Returned
Sildenafil(Vasodilator Antihypertensive)
No Information Returned
Siltuximab
No Information Returned
Silver nitrate
No Information Returned
Silver sulfadiazine
No Information Returned
Simeprevir
No Information Returned
Simeticone
No Information Returned
Simple
No Information Returned
Simvastatin
No Information Returned
Simvastatin and ezetimibe
No Information Returned
Siponimod
No Information Returned
08.02.02
13.05.03
Sirolimus
Angiofibroma from tuberous sclerosis complex
Non Formulary
Formulations :
  • Gel
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD2
Sitagliptin
No Information Returned
Sitaxentan sodium
No Information Returned
Skin protectives,fillers and cleansers
No Information Returned
01.06.04
Sodium acid phosphate with sodium phosphate
Constipation
Green
Formulations :
  • Enema
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
10.01.03
Sodium aurothiomalate
Rheumatoid arthritis
Red
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Severe disease only
Sodium benzoate
No Information Returned
Sodium bicarbonate
No Information Returned
Sodium chloride
No Information Returned
01.01.01
11.08.02
Sodium citrate
Gastric acid neutralisation
Red
Formulations :
  • Oral solution
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Prior to emergency caesarian section
01.06.04
Sodium citrate (Rectal)
Constipation
Green
Formulations :
  • Enema
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
Sodium clodronate
No Information Returned
01.05.04
11.04.02
Sodium cromoglicate
Allergic conjunctivitis
Green
Formulations :
  • Eye drops
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Sodium cromoglycate 2% or Antazoline with Xylometazoline (Otrivine-Antistin) are the preferred antihistamine/anti-inflammatory eye drops
Sodium dihydrogen phosphate dihydrate
No Information Returned
Sodium feredetate
No Information Returned
Sodium fluoride
No Information Returned
Sodium fusidate
No Information Returned
Sodium glycerophosphate
No Information Returned
Sodium hypochlorite
No Information Returned
Sodium lactate
No Information Returned
04.01.01
Sodium oxybate
Narcolepsy
Red
Formulations :
  • Oral solution
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
CD
Important
Narcolepsy in adults - specialist use only.
04.01.01
Sodium oxybate
Narcolepsy
Red
Formulations :
  • Oral solution
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
CD
Un
NHSE
Important
Narcolepsy in children - specialist centres only
Sodium phenylbutyrate
No Information Returned
Sodium picosulfate
No Information Returned
Sodium polystyrene sulfonate
No Information Returned
Sodium stibogluconate
No Information Returned
Sodium tetradecyl sulphate
No Information Returned
Sodium thiosulfate
No Information Returned
Sodium valproate
No Information Returned
04.08.01
Sodium valproate (NON childbearing potential)
Epilepsy
Blue
Formulations :
  • Gastro-resistant tablets
  • Modified release tablets
  • Oral solution
  • Tablets
  • Crushable tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
04.08.01
Sodium valproate (NON childbearing potential)
Epilepsy
Blue
Formulations :
  • Capsules (slow release)
  • Granules (slow release)
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
04.08.01
Sodium valproate (NON childbearing potential)
Epilepsy
Red
Formulations :
  • Injection
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
04.08.01
Sodium valproate (with childbearing potential)
Epilepsy
Amber
Formulations :
  • Gastro-resistant tablets
  • Modified release tablets
  • Oral solution
  • Tablets
  • Crushable tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
SA
Important
Pregnancy Prevention Programme required. See MHRA advice
04.08.01
Sodium valproate (with childbearing potential)
Epilepsy
Amber
Formulations :
  • Capsules (slow release)
  • Granules (slow release)
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
SA
Important
Pregnancy Prevention Programme required. See MHRA advice
04.08.01
Sodium valproate (with childbearing potential)
Epilepsy
Red
Formulations :
  • Injection
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
SA
Important
Pregnancy Prevention Programme required. See MHRA advice
Sodium zirconium cyclosilicate
No Information Returned
Sofosbuvir
No Information Returned
Sofosbuvir/velpatasvir
No Information Returned
Sofosbuvir/velpatasvir/voxilaprevir
No Information Returned
Soft soap
No Information Returned
07.04.02
Solifenacin
Overactive bladder (adults)
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
Important
Preferred
1st line unless contra-indicated
07.04.02
Solifenacin
Overactive bladder (adults)
Green (see narrative)
Formulations :
  • Oral suspension
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
R
Important
Only for patients with swallowing difficulties. Prescribe as solifenacin 1mg/ml oral SUSPENSION
07.04.02
Solifenacin
Overactive bladder (adults)
Non Formulary
Formulations :
  • Oral solution
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Important
Prescribe as solifenacin 1mg/ml oral SUSPENSION
Solifenacin/tamsulosin
No Information Returned
Soluble insulin (Neutral insulin)
No Information Returned
Solvent ether
No Information Returned
Somatorelin
No Information Returned
Somatropin
No Information Returned
Sorafenib
No Information Returned
Sotalol hydrochloride
No Information Returned
Spironolactone
No Information Returned
Spironolactone with loop diuretics
No Information Returned
Spironolactone with thiazides
No Information Returned
Squill
No Information Returned
Squill opiate
No Information Returned
Squill/ipecacuanha
No Information Returned
Stannous fluoride
No Information Returned
Stanozolol
No Information Returned
Stavudine
No Information Returned
Ster larvae
No Information Returned
Sterculia
No Information Returned
Sterile water
No Information Returned
04.08.01
Stiripentol
Epilepsy
Red
Formulations :
  • Capsules
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Initiation and adjustment by consultant paediatricians only.
Streptokinase
No Information Returned
Streptokinase and streptodornase
No Information Returned
Streptomycin
No Information Returned
Strontium ranelate
No Information Returned
01.03.03
01.07.01
Sucralfate
Gastro protection
Red
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
U
Sucrase
No Information Returned
Sucroferric oxyhydroxide
No Information Returned
Sucrose
No Information Returned
Sulconazole nitrate
No Information Returned
Sulfadiazine
No Information Returned
Sulfamethoxypyridazine
No Information Returned
Sulfapyridine
No Information Returned
01.05.01
10.01.03
Sulfasalazine
Gastroenterology indications
Amber
Formulations :
  • Oral suspension
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
01.05.01
10.01.03
Sulfasalazine
Rheumatology indications
Amber
Formulations :
  • Gastro-resistant tablets
  • Oral suspension
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Sulfinpyrazone
No Information Returned
Sulfur
No Information Returned
Sulindac
No Information Returned
Sulpiride
No Information Returned
Sultiame
No Information Returned
04.07.04
Sumatriptan
Migraine (acute)
Green
Formulations :
  • Injection
  • Nasal spray
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Preferred
Prescribe generically.
04.07.04
Sumatriptan
Cluster headaches
Green
Formulations :
  • Injection
  • Nasal spray
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Prescribe generically.
Sumatriptan succinate
No Information Returned
Sunitinib
No Information Returned
Suxamethonium chloride
No Information Returned
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More